Collectively, these findings elucidate a molecular mechanism whereby METTL1 promotes HCC development through tRNA m7G -dependent translational regulation, highlighting METTL1 as a potential therapeutic target in HCC (Figure 2). This evidence concerns the gene METTL1 and hepatocellular carcinoma.